AI assistant
STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2024
Sep 6, 2024
62616_rns_2024-09-06_8039ba0e-861f-4842-990b-68a95e035208.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [136 x 44] intentionally omitted <==
September 6, 2024
BSE Limited
Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001
Scrip code: 532531
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051
Scrip code: STAR
Dear Madam/ Sir,
Sub: Update on partial redemption of Secured, Unlisted, Redeemable, Non-Convertible Debentures
Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
This has reference to the Secured, Unlisted, Redeemable, Non-Convertible Debentures having face value of Rs. 10 Lakhs each aggregating to Rs. 125 Crores issued by the Company on a private placement basis.
In this regard, we wish to inform you that the Company has partially redeemed NCDs aggregating to Rs. 74 Crores along with applicable coupon/ interest rate.
This is for your information and records.
Thanks & Regards, For Strides Pharma Science Limited,
MANJUL Digitally signed by MANJULA R A R Date: 2024.09.06 19:10:58 +05'30'
Manjula Ramamurthy Company Secretary ICSI Membership No. A30515
==> picture [500 x 51] intentionally omitted <==